Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022-2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding from the COVID-19 pandemic. Today, health systems are building a preventive and sustainable ecosystem. Because of waning opportunities in COVID-19 testing, labs across the industry focus on tackling an excess capacity in analyzers. This dynamic is leading to innovative services becoming more widespread for consumers.

The industry comprises two disciplines: pathology and radiology/diagnostic imaging. This study focuses on pathology lab testing services and does not include contract research organizations, food/feed testing, diagnostic imaging, or digital pathology services. The pathology lab testing segment breaks down into routine and specialized (high-end specialized and semi-specialized) testing services. The competitive environment covers hospital labs and independent labs, including multi-chain organized and unorganized labs. This study concludes with a discussion of four growth opportunities industry players should consider to build on trends, maximize economic potential, and sustain value.